Association between Thrombocytopenia and Outcomes in Patients Undergoing Redo Valvular Surgery Utilizing Cardiopulmonary Bypass
Authors:
- 6 June 2024
- journal article
- research article
- Published by Forum Multimedia Publishing LLC in The Heart Surgery Forum
- Vol. 27 (6) , E605-E612
Abstract
Objective: To figure out the incidence of postoperative thrombocytopenia among adult cases undergoing redo valvular surgery with cardiopulmonary bypass (CPB) and to discern its ramifications on early postoperative outcomes. Methods: A cohort comprising 188 cases undergoing redo valvular surgery with CPB between March 2018 and July 2023 was analyzed. It was attempted to stratify cases into two groups on the basis of presence of thrombocytopenia that was defined as a nadir platelet count <71 × 103/μL within 72 hours (n = 45), or absence of thrombocytopenia (n = 143). Comparative evaluation was performed concerning postoperative mortality and morbidity. Logistic regression models were employed to unveil the relationship of thrombocytopenia with clinical outcomes. Results: Thrombocytopenia manifested in 45 (23.94%) cases. Univariate analysis disclosed a significant association of percent change in platelet count with mortality (odds ratio (OR), 1.039, 95% confidence interval (CI), 1.005 to 1.074, p = 0.024), postoperative pneumonia (OR, 1.058, 95% CI, 1.023 to 1.095, p = 0.001), prolonged mechanical ventilation (OR, 1.048, 95% CI, 1.026 to 1.071, p < 0.001), extended intensive care unit (ICU) stay (OR, 1.029, 95% CI, 1.010 to 1.049, p = 0.003), protracted post-operative hospitalization (OR, 1.031, 95% CI, 1.011 to 1.051, p = 0.002), postoperative renal replacement therapy (OR, 1.042, 95% CI, 1.017 to 1.069, p = 0.001), and re-thoracotomy attributable to hemorrhage (OR, 1.040, 95% CI, 1.000 to 1.080, p = 0.047). Multivariate analysis demonstrated that thrombocytopenia, regarded as a categorical variable, was independently correlated with an escalated likelihood of prolonged postoperative hospital stay (OR, 4.926, 95% CI, 1.740 to 13.948, p = 0.003). Conclusions: Thrombocytopenia appeared to be closely linked to escalated in-hospital mortality and postoperative morbidity rates among cases undergoing redo valvular surgery employing CPB. Further investigations with larger, prospective cohorts are essential to validate these outcomes and unravel potential underlying mechanisms.Keywords
This publication has 33 references indexed in Scilit:
- The molecular basis of immune-based platelet disordersClinical Science, 2020
- The Immune Nature of Platelets RevisitedTransfusion Medicine Reviews, 2020
- Reoperative Cardiac Surgery Is a Risk Factor for Long-Term MortalityThe Annals of Thoracic Surgery, 2020
- Thrombocytopenia After Cardiopulmonary Bypass Is Associated With Increased Morbidity and MortalityThe Annals of Thoracic Surgery, 2019
- Clinical Outcomes of Mitral Valve Reoperations in the United States: An Analysis of The Society of Thoracic Surgeons National DatabaseThe Annals of Thoracic Surgery, 2019
- The role of platelets in acute kidney injuryNature Reviews Nephrology, 2018
- Platelets and infectionSeminars in Immunology, 2016
- National trends in utilization and in-hospital outcomes of mechanical versus bioprosthetic aortic valve replacementsThe Journal of Thoracic and Cardiovascular Surgery, 2015
- Incidence and clinical relevance of anti–platelet factor 4/heparin antibodies before cardiac surgeryAmerican Heart Journal, 2010
- CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care settingAmerican Journal of Infection Control, 2008